Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

FLT3-ITD Activates Cytoplasmic Drosha-Dependent Non-Canonical Mechanisms of Mir-155 Biogenesis in Acute Myeloid Leukemia

Le Xuan Truong Nguyen, PhD, Bin Zhang, PhD, Dinh Hoa Hoang, BS, Dandan Zhao, MD, Sergio Branciamore, Davide Maestrini, PhD, Yu-Lin SU, PhD, Sonia Rodriguez, PhD, Flavia Pichiorri, PhD, Steven Rosen, MD, Michael A. Caligiuri, MD, Stephen J. Forman, MD, Ling Li, PhD, Marcin Kortylewski, PhD, Russell Rockne, PhD, Ya-Huei Kuo, PhD, Nadia Carlesso, MD, Guido Marcucci, MD

Blood (2019) 134 (Supplement_1): 2722.

https://doi.org/10.1182/blood-2019-131871

Published: 2019

Journal Articles

Spred1 Insufficiency in the Hematopoietic and/or Vascular Compartments of the Bone Marrow (BM) Niche Promotes Aggressive Leukemogenesis in Chronic Myelogenous Leukemia (CML)

Junjing Qiao, MD PhD, Dandan Zhao, MD, Le Xuan Truong Nguyen, PhD, Herman Wu, BS, Gang Liu, PhD, Shanshan Suo, MD, Huafeng Wang, Yasmin Elhajmoussa, Chen Liang, MD, David Snyder, MD, Haris Ali, MD, Steven Rosen, MD, Nadia Carlesso, MD, Ling Li, PhD, Ya-Huei Kuo, PhD, Guido Marcucci, MD, Bin Zhang, PhD

Blood (2019) 134 (Supplement_1): 3791.

https://doi.org/10.1182/blood-2019-127616

Published: 2019

Journal Articles

A Novel Multiplex NGS-Based Digital MLPA Assay for Copy Number Detection of 700 Target Sequences in Childhood Acute Lymphoblastic Leukemia

Anne Benard, Ilse Zondervan, Jan Schouten, Karel de Groot, Farzaneh Ghazavi, Virinder Sarhadi, Pieter Van Vlierberghe, PhD, Barbara De Moerloose, MD, Christine Harrison, Claire Schwab, Sakari Knuutila, Tim Lammens, Suvi Savola

Blood (2016) 128 (22): 4071.

https://doi.org/10.1182/blood.V128.22.4071.4071

Published: 2016

Journal Articles

The Mutational and Signaling Landscape of Multiple Myeloma Varies Dependent upon Translocation Cyclin D (TC) Subgroup

Caleb K. Stein, MS, Charlotte Pawlyn, MB BChir, Shweta S. Chavan, PhD, Niels Weinhold, PhD, Brian A Walker, PhD, Adam Rosenthal, Ola Landgren, MD, PhD, Peter Leif Bergsagel, MD PhD, Gareth J Morgan, MD PhD

Blood (2016) 128 (22): 4441.

https://doi.org/10.1182/blood.V128.22.4441.4441

Published: 2016

Journal Articles

Overexpression and knockout of miR-126 both promote leukemogenesis

Blood (2015) 126 (17): 2005–2015.

https://doi.org/10.1182/blood-2015-04-639062

Published: 2015

Includes: Supplemental data

Journal Articles

Absence of Spred, a Negative Regulator of Tyrosine Kinase Activity, in Acute Myeloid Leukemia Patients

Valentina Rosso, PhD, Cristina Panuzzo, PhD, Enrico Bracco, PhD, Sonia Carturan, PhD, Valentina Campia, PhD, Alessandra Favole, PhD, Elisabetta Signorino, PhD, Pimjai Niparuk, MD, Chiara Calabrese, PhD, Luciana De Luca, MD, Antonella Caivano, Annalisa Morano, Francesco Frassoni, Giuseppe Saglio, MD, Daniela Cilloni, MD

Blood (2012) 120 (21): 4616.

https://doi.org/10.1182/blood.V120.21.4616.4616

Published: 2012

Journal Articles

Does SPRED1 contribute to leukemogenesis in juvenile myelomonocytic leukemia (JMML)?

Christiane Batz, Henrik Hasle, Eva Bergsträsser, Marry M. van den Heuvel-Eibrink, Marco Zecca, Charlotte M. Niemeyer, Christian Flotho

Blood (2010) 115 (12): 2557–2558.

https://doi.org/10.1182/blood-2009-12-260901

Published: 2010

Journal Articles

Foxo Transcription Factor Activity Is Retained in Quiescent Chronic Myeloid Leukaemia Stem Cells and Activated by Tyrosine Kinase Inhibitors to Mediate “induced-quiescence” in More Mature progenitors.

Daniela Cilloni, MD, PhD, Francesca Pellicano, PhD, Vignir G Helgason, PhD, Cristina Panuzzo, PhD, Francesca Messa, PhD, Brian J Huntly, MD, Elaine Allan, PhD, Francesca Arruga, PhD, Enrico Bracco, PhD, Giuseppe Saglio, MD, Tessa L Holyoake, MD

Blood (2009) 114 (22): 187.

https://doi.org/10.1182/blood.V114.22.187.187

Published: 2009

Journal Articles

SPRED1 disorder and predisposition to leukemia in children

Eric Pasmant, Paola Ballerini, Helene Lapillonne, Christine Perot, Dominique Vidaud, Guy Leverger, Judith Landman-Parker

Blood (2009) 114 (5): 1131.

https://doi.org/10.1182/blood-2009-04-218503

Published: 2009

Journal Articles

The Re-Activation of FoxO3 Transcription Factor in Acute Myeloid Leukaemia Is Responsible for the Induction of a Quiescent Status of Leukaemic Progenitor Cells.

Daniela Cilloni, Cristina Panuzzo, PhD, Francesca Arruga, PhD, Francesca Messa, PhD, Monica Pradotto, PhD, Enrico Bracco, PhD, Alessandro Morotti, MD, Emanuela Messa, Antonia Rotolo, Ilaria Iacobucci, Chiara Marrè, Marisa Pautasso, Giovanni Martinelli, MD, Giuseppe Saglio

Blood (2008) 112 (11): 929.

https://doi.org/10.1182/blood.V112.11.929.929

Published: 2008

Journal Articles

FoxO Transcription Factor Is Delocalized in CML Patients by Bcr-Abl Induced PI3K/AKT Activation and IKK Pathway and Can Be Reactivated by Imatinib Treatment.

Daniela Cilloni, MD, PhD, Cristina Panuzzo, PhD, Francesca Messa, PhD, Francesca Arruga, PhD, Paolo Nicoli, MD, Emanuela Messa, MD, Stefano Ulisciani, MD, Ilaria Iacobucci, PhD, Giovanni Martinelli, MD, Enrico Bracco, PhD, Thea Kalebic, MD, Giuseppe Saglio, MD

Blood (2007) 110 (11): 1010.

https://doi.org/10.1182/blood.V110.11.1010.1010

Published: 2007

Journal Articles

FoxO Transcription Factor Is Delocalized and Inactivated in Acute Myeloid Leukaemia Patients.

Daniela Cilloni, MD, PhD, Cristina Panuzzo, PhD, Francesca Messa, PhD, Francesca Arruga, PhD, Paolo Nicoli, MD, Emanuela Messa, MD, Sonia Carturan, PhD, Ilaria Defilippi, PhD, Ilaria Iacobucci, PhD, Valentina Rosso, PhD, Giovanni Martinelli, MD, Enrico Bracco, PhD, Giuseppe Saglio, MD

Blood (2007) 110 (11): 1251.

https://doi.org/10.1182/blood.V110.11.1251.1251

Published: 2007

Journal Articles

Absence of Spred1, a Negative Regulator of Ras/MAPK Pathway, as a Mechanism Responsible for the Constitutive Activation of RTK Mediated Signalling in Acute Leukemias.

Daniela Cilloni, MD, PhD, Enrico Bracco, PhD, Ilaria Defilippi, PhD, Francesca Messa, PhD, Sonia Carturan, PhD, Daniela Di Giovanni, PhD, Francesca Arruga, PhD, Valentina Rosso, PhD, Renata Catalano, PhD, Emanuela Messa, MD, Alessandro Morotti, MD, Anna Serra, PhD, Giuseppe Saglio, MD

Blood (2005) 106 (11): 2287.

https://doi.org/10.1182/blood.V106.11.2287.2287

Published: 2005

NARROW

FLT3-ITD Activates Cytoplasmic Drosha-Dependent Non-Canonical Mechanisms of Mir-155 Biogenesis in Acute Myeloid Leukemia

Spred1 Insufficiency in the Hematopoietic and/or Vascular Compartments of the Bone Marrow (BM) Niche Promotes Aggressive Leukemogenesis in Chronic Myelogenous Leukemia (CML)

A Novel Multiplex NGS-Based Digital MLPA Assay for Copy Number Detection of 700 Target Sequences in Childhood Acute Lymphoblastic Leukemia

The Mutational and Signaling Landscape of Multiple Myeloma Varies Dependent upon Translocation Cyclin D (TC) Subgroup

Overexpression and knockout of miR-126 both promote leukemogenesis

Absence of Spred, a Negative Regulator of Tyrosine Kinase Activity, in Acute Myeloid Leukemia Patients

Does SPRED1 contribute to leukemogenesis in juvenile myelomonocytic leukemia (JMML)?

Foxo Transcription Factor Activity Is Retained in Quiescent Chronic Myeloid Leukaemia Stem Cells and Activated by Tyrosine Kinase Inhibitors to Mediate “induced-quiescence” in More Mature progenitors.

SPRED1 disorder and predisposition to leukemia in children

The Re-Activation of FoxO3 Transcription Factor in Acute Myeloid Leukaemia Is Responsible for the Induction of a Quiescent Status of Leukaemic Progenitor Cells.

FoxO Transcription Factor Is Delocalized in CML Patients by Bcr-Abl Induced PI3K/AKT Activation and IKK Pathway and Can Be Reactivated by Imatinib Treatment.

FoxO Transcription Factor Is Delocalized and Inactivated in Acute Myeloid Leukaemia Patients.

Absence of Spred1, a Negative Regulator of Ras/MAPK Pathway, as a Mechanism Responsible for the Constitutive Activation of RTK Mediated Signalling in Acute Leukemias.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only